Treatment with warfarin early after bioprosthetic surgical aortic valve replacement is associated with lower mortality and thromboembolism risk but increased major bleeding events.
Advances in stroke, a novel antihypertensive, and new evidence that diabetes drugs may offer CVD benefits for those without diabetes are among the top developments in 2023, on the AHA's annual list.
New comparison studies show the popular weight-loss medications might not reduce certain complications as well as surgical interventions, but there's still plenty of positive news surrounding them.
Utilizing user-friendly, swiftly applicable electrodes, subhairline EEG may improve stroke detection and reduce time to treatment for anterior circulation large vessel occlusion stroke.